Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 23 citing articles:

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
HLA‐G: Function, polymorphisms and pathology
Antonio Arnaiz‐Villena, Ignacio Juárez, Fabio Suárez‐Trujillo, et al.
International Journal of Immunogenetics (2020) Vol. 48, Iss. 2, pp. 172-192
Open Access | Times Cited: 49
Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment
Guoxu Zheng, Lintao Jia, Angang Yang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Intercellular transfer of HLA‐G: its potential in cancer immunology
Aifen Lin, Wei‐Hua Yan
Clinical & Translational Immunology (2019) Vol. 8, Iss. 9
Open Access | Times Cited: 41
Role of HLA-G in Viral Infections
Simon Jasinski‐Bergner, Dominik Schmiedel, Ofer Mandelboim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
A role for both HLA-F and HLA-G in reproduction and during pregnancy?
Gry Persson, Nanna Jørgensen, Line Nilsson, et al.
Human Immunology (2019) Vol. 81, Iss. 4, pp. 127-133
Closed Access | Times Cited: 35
The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis
Huihui Xu, Wei‐Hua Yan, Aifen Lin
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 28
Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
Barbara Seliger, Simon Jasinski‐Bergner, Chiara Massa, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Open Access | Times Cited: 14
Cytokine stimulation of the choriocarcinoma cell line JEG-3 leads to alterations in the HLA-G expression profile
Gry Persson, Julie Birgit Siig Bork, Cecilie Isgaard, et al.
Cellular Immunology (2020) Vol. 352, pp. 104110-104110
Closed Access | Times Cited: 22
HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients
Ali H. Ad’hiah, Noor T. Al-Bayatee
Human Immunology (2022) Vol. 83, Iss. 6, pp. 521-527
Open Access | Times Cited: 13
The HLA-G immune checkpoint: a new immuno-stimulatory role for the α1-domain-deleted isoform
Diana Tronik‐Le Roux, Marina Daouya, Alix Jacquier, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Closed Access | Times Cited: 13
A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome
Ricky B. van de Water, Daniëlle Krijgsman, Ruben D. Houvast, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8265-8265
Open Access | Times Cited: 16
HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet
Alessandro Gambella, Stefano Scabini, Gabriele Zoppoli, et al.
Histochemistry and Cell Biology (2022) Vol. 158, Iss. 6, pp. 535-543
Open Access | Times Cited: 12
European Patent in Immunoncology: From Immunological Principles of Implantation to Cancer Treatment
Franziska M. Würfel, Christoph Winterhalter, Peter Trenkwalder, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1830-1830
Open Access | Times Cited: 16
Prognostic and Clinicopathological Value of Human Leukocyte Antigen G in Gastrointestinal Cancers: A Meta-Analysis
Yongjia Peng, Jian Xiao, Wenyun Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13
Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions
Xia Zhang, Aifen Lin, Qiu-Yue Han, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 12
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer
Astrid Louise Bjørn Bennedsen, Luyi Cai, Rune Petring Hasselager, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Evidence for a shift in placental HLA-G allelic dominance and the HLA-G isoform profile during a healthy pregnancy and preeclampsia
Gry Persson, Christina Seefeldt Stæhr, Freja Syrach Klok, et al.
Biology of Reproduction (2021) Vol. 105, Iss. 4, pp. 846-858
Closed Access | Times Cited: 8
Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study
Enrico Fainardi, Daria Bortolotti, Massimiliano Castellazzi, et al.
Human Immunology (2019) Vol. 81, Iss. 4, pp. 156-161
Closed Access | Times Cited: 8
Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysis
Yingying Zhang, Siying He, Lisha Yu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
HLA-G-mediated immunological tolerance and autoimmunity
Huihui Xu, Aifen Lin, Wei‐Hua Yan
Elsevier eBooks (2021), pp. 265-295
Closed Access | Times Cited: 4
Effect modification between HLA-F and CD56 markers reveals differences in survival for triple-negative breast cancer patients
N Pedersen, Wenna Nascimento Melsted, Thomas Scheike, et al.
Human Immunology (2024) Vol. 85, Iss. 6, pp. 111152-111152
Closed Access
HLA-G: A Novel Immune Checkpoint for Solid Cancer Immunotherapy
Aifen Lin, Wei‐Hua Yan
Springer eBooks (2023), pp. 1-27
Closed Access
Page 1

Scroll to top